158.17MMarket Cap-747P/E (TTM)
8.0900High7.6000Low156.38KVolume8.0700Open8.0900Pre Close1.21MTurnover1.47%Turnover RatioLossP/E (Static)20.76MShares29.700052wk High0.87P/B80.84MFloat Cap7.240052wk Low--Dividend TTM10.61MShs Float624.8000Historical High--Div YieldTTM6.06%Amplitude5.3100Historical Low7.7450Avg Price1Lot Size
Adverum Biotechnologies Stock Forum
NEWS
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
4 MINUTES AGO, 7:00 AM EST
VIA GLOBENEWSWIRE
– Both dose levels (2E11 & 6E10) demonstrate potential best-in-class clinical activity in hard-to-treat patients including treatment burden reduction and maintenance of both visual acuity and anatomic endpoints –
– Preliminary safety data support a favorable benefit-risk pr...
Just I am afriad the 1.2 private offering deal (typically 20% to 10% off to fair value) will pin the price to 1.4 to 1.6 area. Cashless warrant is bad for common investors. Also attract too many day traders. won’t last l...
$EyePoint Pharmaceuticals(EYPT.US)$
$Adverum Biotechnologies(ADVM.US)$
$Regenxbio(RGNX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Kodiak Sciences(KOD.US)$
No comment yet